Exp Neurol, 2008 · DOI: 10.1016/j.expneurol.2007.06.009 · Published: February 1, 2008
Trauma to the central nervous system (CNS) triggers inflammation and activation of the immune system, which can both worsen the damage and stimulate repair mechanisms. The role of neuroinflammation is controversial, with both beneficial and detrimental effects being attributed to various immune components. This review addresses the complexities of neuroinflammation after spinal cord injury (SCI) and discusses therapies that target neuroinflammatory cascades.
Understanding the differences between brain and spinal cord inflammation could lead to novel site-specific therapies.
Acknowledging genetic variability in inflammatory responses suggests that treatments should be tailored to individual patients.
The vasoactive properties of neuroinflammation could be harnessed to deliver drugs to the chronically injured brain or spinal cord.